In BC, the mechanism of action of AIFM2 exhibits subtype-specific differences, with its overexpression promoting tumor cell proliferation, invasion and migration (60); Genome-wide analysis indicates that upregulation of AIFM2 affects BC cell proliferation and patient prognosis (61). This evidence concerns the gene AIFM2 and breast cancer.